Immunotherapy Trial Started in Patients with Inoperable Pancreatic Cancer – Benzinga
|
Immunotherapy Trial Started in Patients with Inoperable Pancreatic Cancer
Benzinga "We are glad to have opportunity to offer the most advanced immunotherapy available today for patients with pancreatic cancer. Having successfully developed similar immunotherapies for patients with hepatocellular carcinoma, now in Phase III trial, and … |
